author-photo

Nataliya Afonina

Bristol-Myers Squibb

5

Papers

359

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

A multi-company assessment of submicron particle levels by NTA and RMM in a wide range of late-phase clinical and commercial biotechnology-derived protein products.

2019 Journal of Pharmaceutical Sciences
Show All
- Source
- Cite
- Save
Citations (6)
Subvisible (2–100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy

2015 Journal of Pharmaceutical Sciences
Show All
- Source
- Cite
- Save
Citations (39)